Emerging World Pharma is an investor in generic based pharmaceutical companies manufacturing within developing nations.
Emerging World Pharma said that the investment will be used to fund generic drug manufacturing facilities in Estonia and eventually expand into Eastern European countries.
Reportedly, Emerging World Pharma’s investment into African Global Pharma Sunyani, Ghana’s generic pharmaceutical facility, is on schedule to be operational by the end of May 2010.
Brandon Keks, president of Emerging World Pharma, said: “We believe the investment into European Global Pharma via Estonia will provide a corridor for continued growth and development of generic pharmaceutical manufacturing into Eastern Europe and surrounding Baltic regions.”